Bernstein, Barry M.,Menon, Rajeev M.,Khatri, Amit,Mensing, Sven,Dutta, Sandeep,Cohen, Daniel E.,Podsadecki, Thomas J.,Brun, Scott C.,Awni, Walid M.,Dumas, Emily O.,Klein, Cheri E.
申请号：
AU2015100972
公开号：
AU2015100972B4
申请日:
2015.07.22
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
#$%^&*AU2015100972B420151008.pdf#####ABSTRACT OF THE DISCLOSURE The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin. 135 6722761_1 (GHMatters) P99395.AU.6 JBORHAM
